Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    Open Studies | "Photorefractive Keratectomy"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Not yet recruiting Study of SAF312 as an Eye Drop for Treatment of Eye Pain Following Photorefractive Keratectomy (PRK) Surgery
Condition: Postoperative Ocular Pain After PRK Surgery
Interventions: Drug: SAF312;   Drug: Placebo
2 Recruiting The Use of MMC During PRK and Its Effect on Postoperative Topical Steroid Requirements
Condition: Corneal Opacity
Interventions: Drug: Mitomycin-C;   Drug: Fluorometholone 1% topical ocular steroid
3 Not yet recruiting Safety and Efficacy of Lotemax Versus FML in Subjects Undergoing PRK for the Correction of Mild to Moderate Myopia, 3- Month Follow-up Study
Condition: Must be PRK Candidate
Interventions: Drug: Fluorometholone(FML);   Drug: Loteprednol (Lotemax)

Study has passed its completion date and status has not been verified in more than two years.